Customize Consent Preferences

We use cookies to help you navigate efficiently and perform certain functions. You will find detailed information about all cookies under each consent category below.

The cookies that are categorized as "Necessary" are stored on your browser as they are essential for enabling the basic functionalities of the site. ... 

Always Active

Necessary cookies are required to enable the basic features of this site, such as providing secure log-in or adjusting your consent preferences. These cookies do not store any personally identifiable data.

Functional cookies help perform certain functionalities like sharing the content of the website on social media platforms, collecting feedback, and other third-party features.

Analytical cookies are used to understand how visitors interact with the website. These cookies help provide information on metrics such as the number of visitors, bounce rate, traffic source, etc.

Performance cookies are used to understand and analyze the key performance indexes of the website which helps in delivering a better user experience for the visitors.

Advertisement cookies are used to provide visitors with customized advertisements based on the pages you visited previously and to analyze the effectiveness of the ad campaigns.

Other cookies are those that are being identified and have not been classified into any category as yet.

Camouflaged cancer cells and their role in spreading metastasis


Colon cancer cells can mask themselves as normal cells in order to bypass the defence system of an organism and spread all over the body, causing metastasis. This is what has been discovered by a research group from the Istituto Clinico Humanitas, in a study designed and led by Luigi Laghi and conducted by Giuseppe Celesti, which has been published on Gastroenterology.

Researchers also managed to unveil the molecular mechanism through which such a mimesis occurs. “We already know that tumor is made not only by cancer cells but also, for the most part, by normal, non-malignant cells, which constitutes the stroma,” explains Alberto Mantovani, scientific director of Humanitas, who supervised the study together with Alberto Malesci, director of the Department of Gastroenterology. What Laghi’s team discovered is that, within the stroma, there may be cancer cells disguised as normal ones.

Researchers managed to attach a molecular marker to cancer cells but, surprisingly, they found such marker also on cells that were far away from the tumor mass and that those cells were quite indiscernible from normal ones. “This could mean that some of the metastatic mechanisms may activate much before than we have always imagined,” says Luigi Laghi.

“At a diagnostic level, this study opens the possibility to predict a tumor’s aggressiveness level and its metastatic potential, with a higher precision compared to a conventional histological exam,” concludes Alberto Malesci. “Also, the molecular marker we used may become extremely useful for non-invasive diagnosis of colon cancer”.

HUMANITAS GROUP

Humanitas is a highly specialized Hospital, Research and Teaching Center. Built around centers for the prevention and treatment of cancer, cardiovascular, neurological and orthopedic disease – together with an Ophthalmic Center and a Fertility Center – Humanitas also operates a highly specialised Emergency Department.